Dividend stocks have crushed non-payers in the return column over the last 50 years. No two dividend stocks are cut from the same cloth, which means proper vetting is needed to snag high-quality incom
New York, NY and Saint-Herblain (France), July 17, 2024 – Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the participants of the Phase 3 trial “Vac
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to discuss his latest trade out of Sharkninja, and how he's thinking about Pfizer at these levels.
The Investment Committee give you their top stocks to watch for the second half.
Eli Lilly, Novo Nordisk, Merck and Pfizer have been highlighted in this Industry Outlook article.
Lee and I have a list of stocks we love to hate, and one of Lee's picks is Pfizer (NYSE: PFE).
Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
The European Commission did not allow the public enough access to information about COVID-19 vaccine purchase agreements it secured with pharmaceutical companies during the pandemic, the EU general co

3 Under $50 Stocks to Buy Now: Q3 Edition

06:00am, Wednesday, 17'th Jul 2024
If you're a DIY investor who's just starting out, you may not have enough cash on the sidelines to buy a stock that's going for north of $4,000 per share. Booking Holdings (NASDAQ: BKNG ), for example
Medical Properties Trust pays investors a high yield, but the stock carries significant risk. Pfizer's more modest yield of 6% is still well above average, and the dividend has been increasing in rece

7 High-Yield Dividend Stocks Beating Inflation

02:00pm, Tuesday, 16'th Jul 2024
At this writing, current inflation rate is 3% over the past 12 months. That's the reading as of the end of June.
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Pfizer (PFE) are worth retaining i
Pfizer (PFE) reachead $29.10 at the closing of the latest trading day, reflecting a +0.62% change compared to its last close.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Over the years, especially the past three, I have become more cautious about the technology sector's blatant overvaluation. Nevertheless, it is difficult to ignore the capabilities of companies such a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE